WO1999011251A1 - Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases - Google Patents
Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases Download PDFInfo
- Publication number
- WO1999011251A1 WO1999011251A1 PCT/SE1998/001526 SE9801526W WO9911251A1 WO 1999011251 A1 WO1999011251 A1 WO 1999011251A1 SE 9801526 W SE9801526 W SE 9801526W WO 9911251 A1 WO9911251 A1 WO 9911251A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- astaxanthin
- medicament
- mammalian muscle
- diseases
- duration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT98943128T ATE230985T1 (en) | 1997-09-04 | 1998-08-26 | USE OF XANTHOPHYLLES IN THE PRODUCTION OF MEDICINAL PRODUCTS TO IMPROVE MUSCLE FUNCTIONAL DURATION OR TO TREAT MUSCLE DISORDERS OR DISEASES |
AU90989/98A AU727349B2 (en) | 1997-09-04 | 1998-08-26 | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
EP98943128A EP1011653B1 (en) | 1997-09-04 | 1998-08-26 | Use of xanthophylles in medicaments for improvement of duration of muscle function or treatment of muscle disorders or diseases |
US09/485,704 US6245818B1 (en) | 1997-09-04 | 1998-08-26 | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
DK98943128T DK1011653T3 (en) | 1997-09-04 | 1998-08-26 | Use of xanthophylls in medications to improve the duration of muscle function or treatment of muscle disorders or disorders |
JP2000508354A JP3660244B2 (en) | 1997-09-04 | 1998-08-26 | Medications to improve the duration of muscle function or to treat muscle disorders or diseases |
CA002299366A CA2299366C (en) | 1997-09-04 | 1998-08-26 | Use of xanthophylls for improvement of duration of muscle function or treatment of muscle disorders or diseases |
DE69810784T DE69810784T2 (en) | 1997-09-04 | 1998-08-26 | USE OF XANTHOPHYLLES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE IMPROVEMENT OF THE MUSCLE FUNCTIONAL PERIOD OR FOR THE TREATMENT OF MUSCLE DISORDER OR DISEASES |
PL98338982A PL338982A1 (en) | 1997-09-04 | 1998-08-26 | Drug for improving duration of muscle action or for treating muscular disorders or diseases |
NO20001087A NO20001087L (en) | 1997-09-04 | 2000-03-02 | Medication for the extension of muscle function or treatment of muscle disorders or diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703191-8 | 1997-09-04 | ||
SE9703191A SE512531C2 (en) | 1997-09-04 | 1997-09-04 | Use of at least one type of xanthophyll for the manufacture of a medicament for the prophylactic and / or therapeutic improvement of mammalian muscle function and / or treatment of mammalian muscle disorders or disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999011251A1 true WO1999011251A1 (en) | 1999-03-11 |
Family
ID=20408142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1998/001526 WO1999011251A1 (en) | 1997-09-04 | 1998-08-26 | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases |
Country Status (13)
Country | Link |
---|---|
US (1) | US6245818B1 (en) |
EP (1) | EP1011653B1 (en) |
JP (1) | JP3660244B2 (en) |
AT (1) | ATE230985T1 (en) |
AU (1) | AU727349B2 (en) |
CA (1) | CA2299366C (en) |
DE (1) | DE69810784T2 (en) |
DK (1) | DK1011653T3 (en) |
ES (1) | ES2191329T3 (en) |
NO (1) | NO20001087L (en) |
PL (1) | PL338982A1 (en) |
SE (1) | SE512531C2 (en) |
WO (1) | WO1999011251A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001072296A1 (en) * | 2000-03-27 | 2001-10-04 | Astacarotene Ab | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US7078040B2 (en) | 2000-03-27 | 2006-07-18 | Fuji Chemical Industry Co., Ltd. | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US20080269349A1 (en) * | 2004-02-04 | 2008-10-30 | Fuji Chemical Industry Co. Ltd. | Gene expression regulating agent |
US7691901B2 (en) | 2004-04-14 | 2010-04-06 | Cardax Pharmaceuticals Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
US9180111B2 (en) | 2005-03-29 | 2015-11-10 | Cardax Pharma, Inc. | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900324B2 (en) | 2000-09-07 | 2005-05-31 | Astrazeneca Ab | Process for preparing a substituted imidazopyridine compound |
SE0003186D0 (en) * | 2000-09-07 | 2000-09-07 | Astrazeneca Ab | New process |
MXPA05001202A (en) * | 2002-07-29 | 2005-11-23 | Hawaii Biotech Inc | Structural carotenoid analogs for the inhibition and amelioration of disease. |
US20050143475A1 (en) * | 2002-07-29 | 2005-06-30 | Lockwood Samuel F. | Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury |
US20050026874A1 (en) * | 2002-07-29 | 2005-02-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease |
US7345091B2 (en) | 2002-07-29 | 2008-03-18 | Cardax Pharmaceuticals, Inc. | Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050148517A1 (en) * | 2002-07-29 | 2005-07-07 | Lockwood Samuel F. | Carotenoid ether analogs or derivatives for controlling connexin 43 expression |
US7521584B2 (en) * | 2002-07-29 | 2009-04-21 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of disease |
US7375133B2 (en) * | 2002-07-29 | 2008-05-20 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease |
US20050059635A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid ester analogs or derivatives for controlling C-reactive protein levels |
US7320997B2 (en) | 2002-07-29 | 2008-01-22 | Cardax Pharmaceuticals, Inc. | Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease |
US20050049248A1 (en) * | 2002-07-29 | 2005-03-03 | Lockwood Samuel Fournier | Carotenoid ether analogs or derivatives for controlling C-reactive protein levels |
US7723327B2 (en) | 2002-07-29 | 2010-05-25 | Cardax Pharmaceuticals, Inc. | Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease |
US7763649B2 (en) | 2002-07-29 | 2010-07-27 | Cardax Pharmaceuticals, Inc. | Carotenoid analogs or derivatives for controlling connexin 43 expression |
US20050004235A1 (en) * | 2002-07-29 | 2005-01-06 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease |
US20050059659A1 (en) * | 2002-07-29 | 2005-03-17 | Lockwood Samuel Fournier | Carotenoid analogs or derivatives for controlling C-reactive protein levels |
AU2002329108A1 (en) * | 2002-09-03 | 2004-03-29 | Centro De Investigacion En Alimentacion Y Desarrollo A.C. | Method of preparing chitosan microcapsules of astaxanthin and product thus obtained |
CN1874772A (en) * | 2003-11-03 | 2006-12-06 | 阿斯利康(瑞典)有限公司 | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
SE0303451D0 (en) * | 2003-12-18 | 2003-12-18 | Astrazeneca Ab | New compounds |
US20060058269A1 (en) * | 2004-04-14 | 2006-03-16 | Lockwood Samuel F | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US20060167319A1 (en) * | 2004-10-01 | 2006-07-27 | Lockwood Samuel F | Methods for the synthesis of unsaturated ketone intermediates useful for the synthesis of carotenoids |
JP5196708B2 (en) * | 2005-02-04 | 2013-05-15 | 富士化学工業株式会社 | Muscle atrophy improving agent and food and drink comprising astaxanthin and / or ester thereof as active ingredients |
JP2010270095A (en) * | 2008-05-30 | 2010-12-02 | Yamaha Motor Co Ltd | Agent for improving cognitive performance |
US10867701B1 (en) * | 2010-06-28 | 2020-12-15 | Heinrich Anhold | System and method for optimizing patient-specific intervention strategies using point of care diagnostics |
JP5924592B2 (en) * | 2013-04-30 | 2016-05-25 | 株式会社ダイセル | Anti-fatigue composition |
CN112057420A (en) * | 2020-09-21 | 2020-12-11 | 中国科学院烟台海岸带研究所 | Astaxanthin spray and preparation method and use method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003226A1 (en) * | 1984-01-25 | 1985-08-01 | L'oreal | Medicinal composition for the treatment or prevention of acne by oral administration |
WO1995000130A1 (en) * | 1993-06-28 | 1995-01-05 | The Howard Foundation | Use of hydrophilic carotenoids for the manufacture of a medicament for the treatment of diseases having an oxygenation mechanism |
WO1996023489A2 (en) * | 1995-02-03 | 1996-08-08 | Basf Aktiengesellschaft | Use of carotinoids for preparing medicaments for treating dermatoses |
EP0770385A1 (en) * | 1995-10-26 | 1997-05-02 | Suntory Limited | Use of astaxanthin for the treatment of stress |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2619491B2 (en) | 1988-08-11 | 1997-06-11 | サントリー株式会社 | Astaxanthin-containing composition |
JPH0665033A (en) | 1992-08-11 | 1994-03-08 | Lion Corp | Composition for oral cavity |
-
1997
- 1997-09-04 SE SE9703191A patent/SE512531C2/en not_active IP Right Cessation
-
1998
- 1998-08-26 CA CA002299366A patent/CA2299366C/en not_active Expired - Lifetime
- 1998-08-26 PL PL98338982A patent/PL338982A1/en unknown
- 1998-08-26 WO PCT/SE1998/001526 patent/WO1999011251A1/en active IP Right Grant
- 1998-08-26 EP EP98943128A patent/EP1011653B1/en not_active Expired - Lifetime
- 1998-08-26 JP JP2000508354A patent/JP3660244B2/en not_active Expired - Lifetime
- 1998-08-26 ES ES98943128T patent/ES2191329T3/en not_active Expired - Lifetime
- 1998-08-26 AU AU90989/98A patent/AU727349B2/en not_active Ceased
- 1998-08-26 US US09/485,704 patent/US6245818B1/en not_active Expired - Lifetime
- 1998-08-26 DE DE69810784T patent/DE69810784T2/en not_active Expired - Lifetime
- 1998-08-26 AT AT98943128T patent/ATE230985T1/en not_active IP Right Cessation
- 1998-08-26 DK DK98943128T patent/DK1011653T3/en active
-
2000
- 2000-03-02 NO NO20001087A patent/NO20001087L/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1985003226A1 (en) * | 1984-01-25 | 1985-08-01 | L'oreal | Medicinal composition for the treatment or prevention of acne by oral administration |
WO1995000130A1 (en) * | 1993-06-28 | 1995-01-05 | The Howard Foundation | Use of hydrophilic carotenoids for the manufacture of a medicament for the treatment of diseases having an oxygenation mechanism |
WO1996023489A2 (en) * | 1995-02-03 | 1996-08-08 | Basf Aktiengesellschaft | Use of carotinoids for preparing medicaments for treating dermatoses |
EP0770385A1 (en) * | 1995-10-26 | 1997-05-02 | Suntory Limited | Use of astaxanthin for the treatment of stress |
Non-Patent Citations (2)
Title |
---|
PATENT ABSTRACTS OF JAPAN, Vol. 14, No. 215, (C-716); & JP,A,02 049 091 (SUNTORY LTD) 19 February 1990. * |
PATENT ABSTRACTS OF JAPAN, Vol. 18, No. 307, (C-1211); & JP,A,06 065 033 (LION CORP) 8 March 1994. * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001072296A1 (en) * | 2000-03-27 | 2001-10-04 | Astacarotene Ab | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US7078040B2 (en) | 2000-03-27 | 2006-07-18 | Fuji Chemical Industry Co., Ltd. | Method of inhibiting the expression of inflammatory cytokines and chemokines |
US8034372B2 (en) * | 2003-03-05 | 2011-10-11 | Nestec, Ltd. | Dietary supplement for athletic pets |
US7727752B2 (en) | 2003-07-29 | 2010-06-01 | Life Technologies Corporation | Kinase and phosphatase assays |
US20080269349A1 (en) * | 2004-02-04 | 2008-10-30 | Fuji Chemical Industry Co. Ltd. | Gene expression regulating agent |
US10828269B2 (en) | 2004-02-04 | 2020-11-10 | Fuji Chemical Industries Co., Ltd. | Reducing muscle atrophy by administering astaxanthin |
US7691901B2 (en) | 2004-04-14 | 2010-04-06 | Cardax Pharmaceuticals Inc. | Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation |
US9180111B2 (en) | 2005-03-29 | 2015-11-10 | Cardax Pharma, Inc. | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
Also Published As
Publication number | Publication date |
---|---|
EP1011653B1 (en) | 2003-01-15 |
EP1011653A1 (en) | 2000-06-28 |
AU727349B2 (en) | 2000-12-14 |
NO20001087D0 (en) | 2000-03-02 |
DE69810784T2 (en) | 2003-11-13 |
JP3660244B2 (en) | 2005-06-15 |
AU9098998A (en) | 1999-03-22 |
PL338982A1 (en) | 2000-12-04 |
SE512531C2 (en) | 2000-03-27 |
ATE230985T1 (en) | 2003-02-15 |
SE9703191L (en) | 1999-03-05 |
CA2299366A1 (en) | 1999-03-11 |
ES2191329T3 (en) | 2003-09-01 |
CA2299366C (en) | 2008-04-22 |
NO20001087L (en) | 2000-03-02 |
DK1011653T3 (en) | 2003-05-26 |
DE69810784D1 (en) | 2003-02-20 |
JP2001514215A (en) | 2001-09-11 |
SE9703191D0 (en) | 1997-09-04 |
US6245818B1 (en) | 2001-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6245818B1 (en) | Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases | |
US6335361B1 (en) | Method of treating benign forgetfulness | |
US9895375B2 (en) | Compositions containing riboflavin and sesamin-class compounds | |
JP2001508804A (en) | Food composition for enhancing metabolism and preventing oxidative stress | |
JP7177534B2 (en) | Maca Compositions and Methods of Use | |
Dulloo et al. | Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity | |
KR20020015346A (en) | Treatment of neurotic disorders | |
KR100304312B1 (en) | Zinc Supplemented Prostate Extract | |
US4200647A (en) | Vitamin A compositions to treat rheumatic disease | |
US6923967B1 (en) | Treatment of dyspepsia | |
US20200214978A1 (en) | Functional chewing gum comprising phytonutrients and adaptogenic herbs | |
US5627152A (en) | Method for increasing bodyweight | |
AU2003244430A1 (en) | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age- related diseases and for prolonging lifespan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998943128 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2299366 Country of ref document: CA Ref country code: CA Ref document number: 2299366 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09485704 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 90989/98 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1998943128 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 90989/98 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998943128 Country of ref document: EP |